The odds of you receiving a biased answer from this website is extremely high. A better question you should be asking yourself is, what was the vibe of the person that interviewed me? Maybe call B+L's customer service or medical information help line and ask them questions about the products you will be representing. Do they sound enthusiastic? Are they knowledgeable? What was their vibe? Ask the hiring manager for people you can contact within the organization. I personally wouldn't hire you for asking such an ignorant question on cafepharma. Don't take that personally. Good luck with your career search.
Vibe? what are you 20? Don’t be concerned with the “vibe”. Just do what is best for you and your family. The company has been here 165+ years......good, bad, and ugly. Asking about the state of the company won’t answer your question.
Are you 120 years old? The subject's use of the word "vibe" is appropriate. The context in which he asks the question is not. " The Good, Bad, and Ugly" is my dad's favorite movie. I question why you didn't mention great? Assuming this company is doing anything great, good, bad, and ugly.
"Company culture" is a more suitable alternative to "vibe." What's the managed care situation for this company's products? A strong company culture will not make up for poor managed care.
A company's culture can only be as strong as the weakest aspect of the company. For example, An Essential Guide To Effective Managed Care In Commercial Pharma
The following is from a pharmacist in Michigan that tried to run Vyzulta scripts through various insurance companies, "Hi. Just ran that eye drop through insurances. I can't find one that covers it. I ran it under blue cross. Medco express scrip. Medicaid. And one of the Medicare part D. Cash price for 5 ml is 452.99 and 2.5 ml is 227.99." What is coverage for Vyzulta like in other states? My intuition tells me that the "vibe" and or "company culture" at B+L is weak. A "significant seven" product with poor to no coverage and extremely high out of pocket costs to the patient helps build a case that Joe Papa is an expensive burden to prosperity.
I'd lower the price of Vyzulta down to about $60/2.5ml and go after the entire market. $60 is still a little high considering latanoprost is $39.99/2.5ml. Maybe $50/2.5ml. Vyzulta was, on average, 5% better in a small number of patients. Vyzulta is nothing more than a glorified generic and it should be priced as such. I'd rather sell 4 bottles at a fair price rather than bribing a doctor to sell 1 bottle.
The Phase II VOYAGER study was a well thought out and executed study, my compliments to the investigators.
Once you have competitive pricing, how do you sell Vyzulta? One would ask a physician the right questions and sell the facts. How important is efficacy when prescribing a treatment for your open-angle glaucoma or ocular hypertensive patients? Vyzulta not only has competitive pricing with latanoprost brand and generic alternatives, but it does a slightly better job at lowering IOP as you can see from our Phase II study which translates into better patient care. When a patient goes to any given pharmacy how do you know which latanoprost manufacturer the pharmacy will dispense to your patient? You don’t have a convenient way of knowing exactly which manufacturer of latanoprost a patient is going to receive. Furthermore, the pharmacy may stock different latanoprost manufacturers from time to time. Bottle shape, size, material, and tip size can impact how much of the medicine the patient instills into their eye which can affect patient outcomes. Prescribing Vyzulta conveniently eliminates these concerns through consistency. Based on our discussion thus far, can you think of any other benefits that Vyzulta provides you and your patients? Vyzulta provides you with peace of mind that you are providing the best possible patient care for your open-angle glaucoma and ocular hypertensive patients. Can you think of any patients in your practice that would benefit from being switched from Latanoprost to Vyzulta? All you are missing is the pricing component for this product.
